Monograph #070

Oregon Grape

Mahonia aquifolium · Oregon Grape Root · Holly-Leaved Barberry · Mountain Grape
★★★★☆ Evidence AMPK / Metabolic Activation NF-κB / Inflammatory Cytokine Axis Root and root bark

Oregon grape root has substantial clinical evidence through berberine research, with additional traditional use evidence as a whole-plant preparation. This section uses the hybrid Clinical Observations + Biomarker Targets format.

01 Identity 02 Compounds 03 Pathways 04 Biomarkers 05 Extraction 07 Dosing 08 Synergies 09 Safety 11 Evidence 12 Protocol

Botanical Profile

Mahonia aquifolium (Pursh) Nutt. — Root and root bark. Native to western North America, from British Columbia to northern California; naturalized in parts of Europe

Root bark: intensely bitter, yellow-orange color from berberine content. Chewing root produces a strongly bitter, slightly astringent sensation with persistent yellow staining of mouth tissues. Dried root has a faint earthy-woody aroma.

Species Integrity

Oregon grape (Mahonia aquifolium) is frequently confused with or substituted by other Mahonia/Berberis species, some of which have lower berberine content. The berberine content varies significantly between species: M. aquifolium root bark contains 3–6% berberine, while some substitutes contain less than 1%.

Active Compound Profile

Berberine
3–6% in root bark; 1–3% in whole root
AMPK activator; NF-κB inhibitor; antimicrobial via DNA intercalation and FtsZ inhibition; modulates gut microbiome; inhibits CYP2D6 and CYP3A4
Berbamine
0.5–2% in root bark
Calcium channel blocker; immunomodulatory; anti-inflammatory via NF-κB pathway; antitumor activity in vitro
Oxyacanthine
0.3–1.5% in root bark
Smooth muscle relaxant; mild hypotensive; antimicrobial synergy with berberine
Jatrorrhizine
0.2–1% in root bark
Antimicrobial; anti-inflammatory; dopamine D1 receptor agonist activity; cholinesterase inhibition
Absorption

Whole-root preparations over isolated berberine: Oregon grape root contains multiple alkaloids (berbamine, oxyacanthine, jatrorrhizine) that may synergistically enhance berberine's activity and provide complementary mechanisms not present in isolated berberine supplements

Mechanism of Action

★★★☆☆ AMPK / Metabolic Activation Berberine activates AMP-activated protein kinase in liver, muscle, and adipose tissue, improving insulin sensitivity, glucose uptake, and fatty acid oxidation
★★★☆☆ NF-κB / Inflammatory Cytokine Axis Berberine inhibits NF-κB activation and downstream production of TNF-α, IL-6, and IL-1β; reduces COX-2 expression
★★★☆☆ Gut Microbiome Modulation Berberine selectively inhibits pathogenic bacteria while promoting beneficial species (Akkermansia, Bifidobacterium); reduces LPS-producing gram-negative overgrowth; improves intestinal barrier function
★★★☆☆ Hepatobiliary / Bile Flow Enhancement Berberine is a cholagogue — stimulates bile production and flow; berbamine provides additional hepatoprotective activity
★★★☆☆ Antimicrobial / SIBO Management Berberine has broad-spectrum antimicrobial activity against bacteria, fungi, and protozoa; effective against common SIBO organisms including methane-producing archaea

What It Moves in Your Labs

BiomarkerDirectionTargetMechanism
Fasting Glucose ↓ Decrease <100 mg/dL AMPK activation improves hepatic glucose regulation and peripheral insulin sensitivity
HbA1c ↓ Decrease <5.7% Sustained glucose regulation via AMPK activation and improved insulin signaling
LDL Cholesterol ↓ Decrease <100 mg/dL Berberine upregulates hepatic LDL receptor expression via PCSK9 inhibition
Triglycerides ↓ Decrease <100 mg/dL AMPK-mediated fatty acid oxidation; improved hepatic lipid metabolism
hs-CRP ↓ Decrease <1.0 mg/L NF-κB inhibition reduces systemic inflammatory marker production

Extraction & Preparation

Decoction (simmered 20–30 min): 60–70% berberine (as water-soluble salts); lower berbamine extraction

Solubility · Slightly soluble in water (especially as salts); soluble in ethanol and methanol; berberine sulfate and chloride forms are more water-solubleMenstruum · 60% ethanol / 40% waterPlant material · Dried Oregon grape root bark, cut and sifted or coarsely groundMaceration time · 4–6 weeks (agitate daily)Ratio · 1:5 (dried)

Dosing Framework

Take Oregon grape tincture or decoction 15–20 minutes before meals for optimal bitter digestive stimulation.

Dose 1
Low / Digestive Bitter: 1–2 mL tincture before meals
The bitter taste triggers cephalic-phase digestive response; hold in mouth briefly before swallowing
Dose 3
Higher / Metabolic: 3–5 mL tincture, 3x daily (or equivalent decoction)
Higher end of whole-root dosing; still below isolated berberine supplement doses (500mg 3x/day); monitor blood glucose if on diabetes medications

Synergy Partners

★★★☆☆ Milk Thistle (Silybum marianum) Silymarin inhibits P-glycoprotein efflux of berberine, increasing systemic bioavailability 2–3x; complementary hepatoprotective action supports liver-biliary function
★★★☆☆ Dandelion Root (Taraxacum officinale) Complementary cholagogue and choleretic action; dandelion enhances bile production while berberine stimulates bile flow; synergistic hepatobiliary support
★★★☆☆ Oregano Oil (Origanum vulgare) Carvacrol and berberine target SIBO pathogens through different antimicrobial mechanisms; combination broadens antimicrobial spectrum
★★★☆☆ Ginger (Zingiber officinale) Ginger's prokinetic action complements berberine's antimicrobial action in SIBO — kill pathogens while restoring motility to prevent recurrence
Signature Stack

THE BITTER ROOTS PROTOCOL
Components: Oregon Grape (root bark) + Dandelion Root + Milk Thistle (seed) + Ginger (rhizome) · Multi-pathway convergence: Berberine antimicrobial + bile flow enhancement (Oregon grape + dandelion) + P-gp inhibition for berberine bioavailability (milk thistle) + prokinetic motility support (ginger) · The Bitter Roots Protocol targets the gut-liver-thyroid axis that is disrupted in Hashimoto's. Gut dysbiosis drives autoimmune activation; impaired bile flow reduces T4-to-T3 conversion; SIBO causes nutrient malabsorption. This stack addresses all three nodes. · Practical integration: Oregon grape and dandelion root decoction as daily pre-meal bitter tonic; milk thistle capsule with meals; ginger tea or fresh ginger in cooking throughout the day.

Contraindications & Interactions

Avoid Pregnancy Berberine stimulates uterine contractions and has shown embryotoxicity in animal studies. AHPA Class 2b — contraindicated in pregnancy.
Minor Lactation Berberine transfers to breast milk and has caused kernicterus-like jaundice displacement in neonatal animal models. May displace bilirubin from albumin binding sites.
Minor Drug interactions (CYP3A4 / CYP2D6) Berberine inhibits CYP3A4 and CYP2D6 enzymes and P-glycoprotein, potentially increasing blood levels of many pharmaceuticals including cyclosporine, statins, and SSRIs.
Minor Hypoglycemia risk Berberine lowers blood glucose significantly; combination with diabetes medications (metformin, sulfonylureas, insulin) may cause hypoglycemia.
Minor Long-term microbiome effects Berberine's antimicrobial activity is broad-spectrum; prolonged continuous use may deplete beneficial bacteria along with pathogens.

Evidence Base

★★★★☆ Blood Glucose Regulation Strong — Multiple RCTs demonstrate efficacy comparable to metformin
★★★★☆ Lipid Profile Improvement Strong — Consistent LDL and triglyceride reduction across multiple trials
★★★☆☆ SIBO / Antimicrobial Moderate — One key RCT plus strong mechanistic data
★★★☆☆ Psoriasis (Topical) Moderate — Several controlled trials with positive results
★★★☆☆ Gut Microbiome Modulation Moderate — Emerging evidence; strong mechanistic rationale

Evidence Gaps

The highest-value research gap for Meridian Medica: no published study has evaluated whole Oregon grape root preparations (as opposed to isolated berberine) for metabolic or gut microbiome endpoints. The whole-root alkaloid complex (berberine + berbamine + oxyacanthine + jatrorrhizine) may have synergistic effects absent from isolated berberine. A comparative trial of whole Oregon grape root tincture vs isolated berberine for SIBO eradication or metabolic markers in Hashimoto's patients would directly test the whole-plant advantage hypothesis.

Quality Alert

Oregon grape root has moderate adulteration risks:

Protocol Integration

Layer 1: Hypothalamic / Autonomic — HPA axis, circadian rhythm, stress response

Layer 2: Systemic Nutritional Repletion — Micronutrient optimization, antioxidant defense

Layer 3: Gut Permeability / Microbiome — Tight junction repair, motility, SIBO management

Recipe Integration
Bitter Root Digestive Tonic (signature preparation)
1/2 cup decoction before meals (~30–50mg berberine per dose)
Feed the Markers

Oregon grape appears in the following Meridian Medica protocol contexts: